Press Releases

Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning

06/03/21

Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India

06/01/21

Auris Medical Holding to Present at LD Micro Invitational XI Conference

05/28/21

Auris Medical Announces Completion of Bentrio Conformity Assessment Procedure for Marketing in EU

05/25/21

Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo

05/14/21

Auris Medical Provides Update on Bentrio Program in Allergy

05/07/21

Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch

04/13/21

Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021

04/08/21

Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results

03/31/21

Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, 2021

03/24/21

Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis

01/29/21